Position in PFE
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$1,403,943
+$706,793 QoQ
Shares Held
49,998
+78.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ABN AMRO Bank N.V. holds $948,098,619 across 8 Drug Manufacturers - General names. PFE ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,445,171 | $482,236,624 | |
| 2 | LLY |
ELI LILLY & Co
|
239,700 | $220,468,869 | |
| 3 | ABBV |
AbbVie Inc.
|
864,389 | $187,995,963 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
195,724 | $27,278,053 | |
| 5 | MRK |
Merck & Co., Inc.
|
147,377 | $17,727,979 | |
| 6 | JNJ |
Johnson & Johnson
|
37,023 | $9,049,902 | |
| 7 | AMGN |
Amgen Inc
|
5,506 | $1,937,286 | |
| 8 | PFE |
Pfizer Inc
This page
|
49,998 | $1,403,943 |
All Filings in PFE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,403,943 | 49,998 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $697,150 | 27,998 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $322,908 | 12,673 | Shares | Sole | 2025-11-05 | |
| 2024-09-30 | $201,798 | 6,973 | Shares | Sole | 2025-08-28 | |
| 2023-12-31 | $331,286 | 11,507 | Shares | Sole | 2025-08-28 | |
| 2023-09-30 | $405,403 | 12,222 | Shares | Sole | 2025-08-28 | |
| No filing history on record for this holder in this stock. | ||||||